CJC 1295 with DAC (5mg)

General Information about our CJC-1295 For Sale

The CJC-1295 peptide acts like natural hormones in the body that help release growth hormone. It connects well with special spots called receptors in the pituitary gland. This connection leads to more growth hormone being made and released into the body. Studies show that after taking CJC-1295, the levels of human growth hormone can stay high for a few days.

Also, a study suggests that when CJC-1295 is given, it might attach to specific receptors in the pituitary gland. This connection could start a series of events in the body that make more growth hormone and spread it around.

CJC-1295 Benefits

CJC-1295 offers various benefits for the body, particularly in enhancing the production of growth hormone. From improving muscle growth to promoting fat loss, this peptide has gained attention for its potential advantages.

Here are the benefits of CJC-1295 (with DAC) according to research:

• Increased growth hormone production
• Enhanced muscle growth
• Improved fat loss
• Better recovery
• Increased bone density
• Improved sleep
• Enhanced skin health
• Increased energy levels

Abuse Warning

References and Further Read

1. Sackmann-Sala, L., Ding, J., Frohman, L. A., & Kopchick, J. J. (2009). Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. Growth Hormone & IGF Research, 19(6), 471-477.
2. Van Hout, M. C., & Hearne, E. (2016). Netnography of female use of the synthetic growth hormone CJC-1295: pulses and potions. Substance Use & Misuse, 51(1), 73-84.
3. Alba, M., Fintini, D., Sagazio, A., Lawrence, B., Castaigne, J. P., Frohman, L. A., & Salvatori, R. (2006). Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. American Journal of Physiology-Endocrinology and Metabolism, 291(6), E1290-E1294.
4. Knoop, A., Thomas, A., Fichant, E., Delahaut, P., Schänzer, W., & Thevis, M. (2016). Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS. Analytical and Bioanalytical Chemistry, 408, 3145-3153.
5. 
   
   McDonald J, Lambert DG. Drug-receptor interactions in anaesthesia. BJA Educ. 2022 Jan;22(1):20-25. doi: 10.1016/j.bjae.2021.07.009. Epub 2021 Oct 14. PMID: 34992797; PMCID: PMC8703152.